Enliven Therapeutics, Inc. (ELVN) KPIs and segments
ELVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$46.85−0.77 (-1.62%)
Close on Nov 17, 2026Market cap $3.43BP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Enliven Therapeutics's business
Coming soon
This tab will track the numbers specific to Enliven Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?